Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.

Item

http://www.wikidata.org/entity/Q45922582

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.

@en

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.

@nl

type

Item

label

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.

@en

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.

@nl

prefLabel

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.

@en

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.

@nl

P1476

Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line

@en

P2093

E Ciabatti

http://www.w3.org/2001/XMLSchema#string

F Guerrini

http://www.w3.org/2001/XMLSchema#string

M Canestraro

http://www.w3.org/2001/XMLSchema#string

M Petrini

http://www.w3.org/2001/XMLSchema#string

S Piaggi

http://www.w3.org/2001/XMLSchema#string

P2860

The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome.

PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells.

Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation.

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells.

P2888

leu.2009.119

P304

1935-1938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2009.119

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rossana Maffei

Roberto Marasca

Sara Galimberti

P577

2009-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26689446

http://www.w3.org/2001/XMLSchema#string

P6179

1014186902

http://www.w3.org/2001/XMLSchema#string

P698

19626048

http://www.w3.org/2001/XMLSchema#string